svb.com

3 weeks ago | svb.com | Michael Ritter |Tim Lew

Early-stage life science and healthcare founders face fundraising challenges. Learn how trusted partners and non-dilutive funding can help overcome these hurdles.

Jan 1, 2025 | svb.com | Anthony Vassallo |Josh Pherigo

Find out how we expect payments, AI and gaming will accelerate crypto adoption in 2025. Drawing from our proprietary data, industry insights and global data, SVB’s experts explore the current and future crypto market.

Oct 23, 2024 | svb.com

While fintech companies face significant headwinds – from high interest rates to increasing regulatory oversight – they are also finding opportunity in 2024, according to the latest Future of Fintech Report from Silicon Valley Bank (SVB), a division of First Citizens Bank. Venture capital (VC) investment remains muted, hovering near a six-year low for the sector, as deal flow has shifted toward the early stage, with more than three seed deals for every one series A. Artificial intelligence (AI) is also emerging as a bright spot for the industry as investors and founders explore its growing role in the sector.

Sep 17, 2024 | svb.com | Anton Xavier

The third part of the series on non-dilutive funding options looks at ARPA-H for biotech startups. In this article, best practices are shared on how biotech companies can best navigate these funding sources, and how to better prepare for applying.

Sep 13, 2024 | svb.com | Anthony Vassallo |Josh Pherigo

Explore the resurgence of venture capital (VC) investing in the crypto sector driven by a sustained bull market. Read more to stay informed and get ahead.